https://assets.capyfin.com/instruments/678fdc13234e27009c5d64a4.png avatar
Acasti Pharma
🇺🇸 NASDAQ:GRCE
•
Jun 30, 2024

Acasti Pharma Q1 2025 Earnings Report

Total Revenue
$0
EPS
-$0.24
Previous year: -$0.54
-55.6%
Gross Profit
-$1K
Cash and Equivalents
$19.4M
Previous year: $21.6M
-10.3%
Free Cash Flow
-$3.6M
Total Assets
$69.7M
Previous year: $73M
-4.5%

Acasti Pharma Revenue

Acasti Pharma EPS